CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-14 | FOUSE JACQUALYN A Director | Option exercise | +11,333 | 86,230 | ||
| 2023-02-14 | FOUSE JACQUALYN A Director | Option exercise · Restricted stock units | −11,333 | 0 | ||
| 2023-02-14 | Burns James William Chief Legal Officer | Shares withheld for taxes | −643 | $28.44 | $18K | 22,409 |
| 2023-02-14 | Gheuens Sarah Chief Medical Officer | Shares withheld for taxes | −758 | $28.44 | $22K | 17,009 |
| 2023-02-14 | Washburn Theodore James Jr. Principal Accounting Officer | Shares withheld for taxes | −273 | $28.44 | $8K | 3,172 |
| 2023-02-13 | Schenkein David P Director | Option exercise | +20,000 | $9.05 | $181K | 137,879 |
| 2023-02-13 | Schenkein David P Director | Sale | −20,000 | $28.62 | $572K | 117,879 |
| 2023-02-13 | Schenkein David P Director | Option exercise · Stock option (right to buy) | −20,000 | 76,363 | ||
| 2023-02-10 | Burns James William Chief Legal Officer | Option exercise | +1,834 | 23,052 | ||
| 2023-02-10 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units | −1,834 | 1,833 | ||
| 2023-02-10 | Gheuens Sarah Chief Medical Officer | Option exercise | +2,162 | 17,767 | ||
| 2023-02-10 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units | −2,162 | 2,162 | ||
| 2023-02-10 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise | +777 | 3,445 | ||
| 2023-02-10 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise · Restricted stock units | −777 | 777 | ||
| 2023-02-01 | Washburn Theodore James Jr. Principal Accounting Officer | Grant or award · Restricted stock units | +6,896 | 6,896 | ||
| 2023-01-30 | Schenkein David P Director | Option exercise | +20,000 | $9.05 | $181K | 137,879 |
| 2023-01-30 | Schenkein David P Director | Sale | −16,700 | $29.22 | $488K | 121,179 |
| 2023-01-30 | Schenkein David P Director | Sale | −3,300 | $29.88 | $99K | 117,879 |
| 2023-01-30 | Schenkein David P Director | Option exercise · Stock option (right to buy) | −20,000 | 96,363 | ||
| 2023-01-17 | Schenkein David P Director | Option exercise | +20,000 | $9.05 | $181K | 137,879 |
Page 32 of 48 · 941 trades